Sarepta Announces FDA Approval of ELEVIDYS

Поделиться
HTML-код
  • Опубликовано: 9 сен 2024
  • Dr. Gordon Smith talks with Dr. Hoda Abdel-Hamid about the recent FDA approval for the first ever gene therapy for Duchenne muscular dystrophy.
    Visit NPUb.org/Podcast for associated article links.

Комментарии • 5

  • @kentneumann5209
    @kentneumann5209 5 месяцев назад

    They should have opened the discussion with the 3.5 million dollar cost per patient.
    That would have saved me all the time i spent listening to the rest of the vid. Time i could have been spending with my kid. Time that he doesnt have to spare.

  • @dayanemoraesvieirasouza2478
    @dayanemoraesvieirasouza2478 7 месяцев назад

    Eu acho muito caro

  • @kentneumann5209
    @kentneumann5209 5 месяцев назад

    $3.5 million per patient.

  • @sarabnagra3456
    @sarabnagra3456 3 месяца назад

    Very costly 😢

  • @yusufkus4141
    @yusufkus4141 14 дней назад

    Please diye kas hastasıyım